# Westamerica Bancorporation: financial statements, quarterly

WABC · Nasdaq · CIK 311094 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wabc.md) · [Financials](/companies/wabc/financials.md) · [Filings](/companies/wabc/filings.md) · [Insiders](/companies/wabc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wabc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [1.1](/filings/0001171843-23-006860.md) | [1.7 d](/filings/0001171843-24-001054.md) | [3.0](/filings/0001171843-24-002705.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.3](/filings/0001171843-24-006167.md) | [15.4 d](/filings/0001171843-26-001195.md) | [13.0](/filings/0001171843-25-003020.md) | [12.7](/filings/0001171843-25-005101.md) | [12.7](/filings/0001171843-25-007134.md) | [12.0 d](/filings/0001171843-26-001195.md) | [10.8](/filings/0001171843-26-003210.md) | [10.0](/filings/0001171843-26-005234.md) | [9.7](/filings/0001171843-25-007134.md) | [10.0 d](/filings/0001171843-26-001195.md) | [9.1](/filings/0001171843-26-003210.md) | [9.3](/filings/0001171843-26-005234.md) |
| Net income | $m | [41.6](/filings/0001171843-24-006167.md) | [39.5](/filings/0001171843-24-001054.md) | [36.4](/filings/0001171843-25-003020.md) | [35.5](/filings/0001171843-25-005101.md) | [35.1](/filings/0001171843-25-007134.md) | [31.7 d](/filings/0001171843-26-001195.md) | [31.0](/filings/0001171843-26-003210.md) | [29.1](/filings/0001171843-26-005234.md) | [28.3](/filings/0001171843-25-007134.md) | [27.8 d](/filings/0001171843-26-001195.md) | [27.4](/filings/0001171843-26-003210.md) | [27.4](/filings/0001171843-26-005234.md) |
| Diluted EPS | $ per share | [1.56](/filings/0001171843-24-006167.md) | [1.48](/filings/0001171843-24-001054.md) | [1.37](/filings/0001171843-25-003020.md) | [1.33](/filings/0001171843-25-005101.md) | [1.31](/filings/0001171843-25-007134.md) | not reported | [1.16](/filings/0001171843-26-003210.md) | [1.12](/filings/0001171843-26-005234.md) | [1.12](/filings/0001171843-25-007134.md) | not reported | [1.13](/filings/0001171843-26-003210.md) | [1.17](/filings/0001171843-26-005234.md) |
| Basic EPS | $ per share | [1.56](/filings/0001171843-24-006167.md) | [1.48](/filings/0001171843-24-001054.md) | [1.37](/filings/0001171843-25-003020.md) | [1.33](/filings/0001171843-25-005101.md) | [1.31](/filings/0001171843-25-007134.md) | not reported | [1.16](/filings/0001171843-26-003210.md) | [1.12](/filings/0001171843-26-005234.md) | [1.12](/filings/0001171843-25-007134.md) | not reported | [1.13](/filings/0001171843-26-003210.md) | [1.17](/filings/0001171843-26-005234.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [6,567](/filings/0001171843-23-006860.md) | [6,365](/filings/0001171843-25-001156.md) | [6,465](/filings/0001171843-24-002705.md) | [6,312](/filings/0001171843-24-004595.md) | [6,161](/filings/0001171843-24-006167.md) | [6,076](/filings/0001171843-26-001195.md) | [5,967](/filings/0001171843-25-003020.md) | [5,825](/filings/0001171843-25-005101.md) | [5,914](/filings/0001171843-25-007134.md) | [5,960](/filings/0001171843-26-005234.md) | [5,864](/filings/0001171843-26-003210.md) | [5,805](/filings/0001171843-26-005234.md) |
| Total liabilities | $m | [5,919](/filings/0001171843-23-006860.md) | [5,592](/filings/0001171843-25-001156.md) | [5,673](/filings/0001171843-24-002705.md) | [5,497](/filings/0001171843-24-004595.md) | [5,252](/filings/0001171843-24-006167.md) | [5,186](/filings/0001171843-26-001195.md) | [5,043](/filings/0001171843-25-003020.md) | [4,903](/filings/0001171843-25-005101.md) | [4,983](/filings/0001171843-25-007134.md) | [5,027](/filings/0001171843-26-005234.md) | [4,982](/filings/0001171843-26-003210.md) | [4,952](/filings/0001171843-26-005234.md) |
| Short-term borrowings | $m | [115](/filings/0001171843-23-006860.md) | [58.2](/filings/0001171843-25-001156.md) | [50.3](/filings/0001171843-24-002705.md) | not reported | not reported | [120](/filings/0001171843-26-001195.md) | [113](/filings/0001171843-25-003020.md) | [101](/filings/0001171843-25-005101.md) | [134](/filings/0001171843-25-007134.md) | [137](/filings/0001171843-26-005234.md) | [144](/filings/0001171843-26-003210.md) | [132](/filings/0001171843-26-005234.md) |
| Shareholders' equity | $m | [648](/filings/0001171843-24-006167.md) | [773](/filings/0001171843-26-001195.md) | [792](/filings/0001171843-25-005101.md) | [816](/filings/0001171843-25-007134.md) | [909](/filings/0001171843-25-007134.md) | [890](/filings/0001171843-26-005234.md) | [923](/filings/0001171843-26-005234.md) | [922](/filings/0001171843-26-005234.md) | [932](/filings/0001171843-25-007134.md) | [934](/filings/0001171843-26-005234.md) | [883](/filings/0001171843-26-005234.md) | [853](/filings/0001171843-26-005234.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [58.5 d](/filings/0001171843-24-006167.md) | [(8.0) d](/filings/0001171843-26-001195.md) | [52.2](/filings/0001171843-25-003020.md) | [19.0 d](/filings/0001171843-25-005101.md) | [40.6 d](/filings/0001171843-25-007134.md) | [29.8 d](/filings/0001171843-26-001195.md) | [42.4](/filings/0001171843-26-003210.md) | [23.5 d](/filings/0001171843-26-005234.md) | [29.4 d](/filings/0001171843-25-007134.md) | [26.6 d](/filings/0001171843-26-001195.md) | [39.7](/filings/0001171843-26-003210.md) | [15.5 d](/filings/0001171843-26-005234.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001171843-24-006167.md) | [0.3 d](/filings/0001171843-26-001195.md) | [0.1](/filings/0001171843-25-003020.md) | [0.5 d](/filings/0001171843-25-005101.md) | [0.5 d](/filings/0001171843-25-007134.md) | [0.7 d](/filings/0001171843-26-001195.md) | [0.2](/filings/0001171843-26-003210.md) | [0.7 d](/filings/0001171843-26-005234.md) | [0.7 d](/filings/0001171843-25-007134.md) | [0.6 d](/filings/0001171843-26-001195.md) | [1.0](/filings/0001171843-26-003210.md) | [0.3 d](/filings/0001171843-26-005234.md) |
| Dividends paid | $m | [11.7 d](/filings/0001171843-24-006167.md) | [11.7 d](/filings/0001171843-26-001195.md) | [11.7](/filings/0001171843-25-003020.md) | [11.7 d](/filings/0001171843-25-005101.md) | [11.7 d](/filings/0001171843-25-007134.md) | [11.7 d](/filings/0001171843-26-001195.md) | [11.8](/filings/0001171843-26-003210.md) | [12.0 d](/filings/0001171843-26-005234.md) | [11.7 d](/filings/0001171843-25-007134.md) | [11.5 d](/filings/0001171843-26-001195.md) | [11.3](/filings/0001171843-26-003210.md) | [11.3 d](/filings/0001171843-26-005234.md) |
| Share repurchases | $m | [0.0 d](/filings/0001171843-24-006167.md) | [0.0 d](/filings/0001171843-26-001195.md) | [0.2](/filings/0001171843-25-003020.md) | [0.0 d](/filings/0001171843-25-005101.md) | [0.0 d](/filings/0001171843-25-007134.md) | [0.0 d](/filings/0001171843-26-001195.md) | [18.2](/filings/0001171843-26-003210.md) | [38.3 d](/filings/0001171843-26-005234.md) | [23.9 d](/filings/0001171843-25-007134.md) | [23.3 d](/filings/0001171843-26-001195.md) | [51.0](/filings/0001171843-26-003210.md) | [41.5 d](/filings/0001171843-26-005234.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.9](/filings/0001171843-23-006860.md) | [26.9](/filings/0001171843-24-002705.md) | [26.6](/filings/0001171843-24-004595.md) | [26.7](/filings/0001171843-24-006167.md) | [26.7](/filings/0001171843-25-003020.md) | [26.7](/filings/0001171843-25-005101.md) | [26.7](/filings/0001171843-25-007134.md) | [26.6](/filings/0001171843-26-003210.md) | [25.9](/filings/0001171843-26-005234.md) | [25.3](/filings/0001171843-25-007134.md) | [24.3](/filings/0001171843-26-003210.md) | [23.3](/filings/0001171843-26-005234.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,111,153 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001171843-26-005234.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.